Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14574808rdf:typepubmed:Citationlld:pubmed
pubmed-article:14574808lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:14574808lifeskim:mentionsumls-concept:C0002844lld:lifeskim
pubmed-article:14574808lifeskim:mentionsumls-concept:C0006098lld:lifeskim
pubmed-article:14574808lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:14574808lifeskim:mentionsumls-concept:C0205289lld:lifeskim
pubmed-article:14574808lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:14574808pubmed:issue6lld:pubmed
pubmed-article:14574808pubmed:dateCreated2003-10-24lld:pubmed
pubmed-article:14574808pubmed:abstractTextTo assess the effect of the maximal androgen blockade(MAB) and MAB combined with 125I brachytherapy on prostatic cancer.lld:pubmed
pubmed-article:14574808pubmed:languagechilld:pubmed
pubmed-article:14574808pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14574808pubmed:citationSubsetIMlld:pubmed
pubmed-article:14574808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14574808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14574808pubmed:statusMEDLINElld:pubmed
pubmed-article:14574808pubmed:monthSeplld:pubmed
pubmed-article:14574808pubmed:issn1009-3591lld:pubmed
pubmed-article:14574808pubmed:authorpubmed-author:LiuJingJlld:pubmed
pubmed-article:14574808pubmed:authorpubmed-author:ZhangYuanYlld:pubmed
pubmed-article:14574808pubmed:authorpubmed-author:YangJian-JunJ...lld:pubmed
pubmed-article:14574808pubmed:authorpubmed-author:SuYunYlld:pubmed
pubmed-article:14574808pubmed:authorpubmed-author:YaoMao-YinMYlld:pubmed
pubmed-article:14574808pubmed:authorpubmed-author:HuXiang-NongX...lld:pubmed
pubmed-article:14574808pubmed:issnTypePrintlld:pubmed
pubmed-article:14574808pubmed:volume9lld:pubmed
pubmed-article:14574808pubmed:ownerNLMlld:pubmed
pubmed-article:14574808pubmed:authorsCompleteYlld:pubmed
pubmed-article:14574808pubmed:pagination434-5lld:pubmed
pubmed-article:14574808pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:meshHeadingpubmed-meshheading:14574808...lld:pubmed
pubmed-article:14574808pubmed:year2003lld:pubmed
pubmed-article:14574808pubmed:articleTitle[Maximal androgen blockade and maximal androgen blockade combined with 125I brachytherapy for prostatic cancer].lld:pubmed
pubmed-article:14574808pubmed:affiliationDepartment of Urology, Affiliated Hospital of Medical College of Southeast University, Nanjing, Jiangsu 210009, China.lld:pubmed
pubmed-article:14574808pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14574808pubmed:publicationTypeEnglish Abstractlld:pubmed